Tobacco-based COVID-19 vaccine ready for testing
British American Tobacco (BAT) has announced that it has a COVID-19 vaccine ready for human testing following positive pre-clinical trials. The vaccine uses proteins from tobacco leaves and will progress to Phase 1 trials if approved by the US Food and Drug Administration (FDA).